首页|持续气道正压通气辅助治疗OSAHS的效果及对血清IL-6表达的影响分析

持续气道正压通气辅助治疗OSAHS的效果及对血清IL-6表达的影响分析

扫码查看
目的 探讨持续气道正压通气辅助治疗阻塞性睡眠呼吸暂停低通气综合征(obstructive sleep apneahy-popnea syndrome,OSAHS)的效果及对血清白细胞介素-6(interleukin-6,IL-6)表达的影响.方法 方便选取2021年8月—2023年6月新疆生产建设兵团第六师医院诊治的72例OSAHS患者作为研究对象,根据不同治疗方法分为研究组与常规组,每组36例.常规组给予常规治疗,研究组在常规组的基础上给予持续气道正压通气辅助治疗,两组均治疗观察4周.比较两组患者肺功能指标、血清IL-6水平、呼吸暂停低通气指数、最长呼吸暂停时间及并发症发生率.结果 治疗4周后,两组患者肺功能均优于治疗前,且研究组第1秒用力呼气容积和一秒率值均高于常规组,差异有统计学意义(P均<0.05).治疗4周后,研究组呼吸暂停低通气指数为(8.39±2.11)次/h、最长呼吸暂停时间为(21.37±2.87)s,低于常规组的(10.98±2.33)次/h、(32.39±3.38)s,差异有统计学意义(t=4.944、14.912,P均<0.05).治疗4周后,两组患者血清IL-6水平均低于治疗前,且研究组低于常规组,差异有统计学意义(P均<0.05).研究组并发症总发生率低于常规组,差异有统计学意义(P<0.05).结论 持续气道正压通气辅助治疗OSAHS能改善患者的肺功能,降低患者的呼吸暂停低通气指数,缩短最长呼吸暂停时间,还可抑制血清IL-6水平,降低患者的并发症发生率.
The Effect of Continuous Positive Airway Pressure Ventilation as an Adju-vant Therapy for OSAHS and Its Impact on Serum IL-6 Expression
Objective To investigate the efficacy of continuous positive airway pressure ventilation in the adjunctive treatment of obstructive sleep apnea hypoventilation syndrome(OSAHS)and its effect on serum interleukin-6(IL-6)expression.Methods A total of 72 OSAHS patients diagnosed and treated in the Sixth Division Hospital of Xinjiang Production and Construction Corps from August 2021 to June 2023 were conveniently selected as the study objects and divided into study group and routine group according to different treatment methods,with 36 cases in each group.The routine group was given routine treatment,and the study group was given continuous positive airway pressure ad-juvant treatment on the basis of the routine group.Both groups were observed for 4 weeks.Pulmonary function index,serum IL-6 level,apnea hypopnea index,longest apnea time and complication rate were compared between the two groups.Results After 4 weeks of treatment,the lung function of both groups was better than before treatment,and the values of forced expiratory volume in the first second and the ratio of forced expiratory volume in first second and forced vital copacity in the study group were higher than those in the routine group,the differences were statistically significant(all P<0.05).After 4 weeks of treatment,the apnea hypopnea index was(8.39±2.11)times/h and the longest apnea time was(21.37±2.87)s in the study group,which were lower than those in the routine group(10.98±2.33)times/h and(32.39±3.38)s,and the differences were statistically significant(t=4.944,14.912,both P<0.05).After 4 weeks of treatment,the serum IL-6 level in two groups was lower than before treatment,and the study group was lower than the routine group,the differences were statistically significant(all P<0.05).The total complication rate of the study group was lower than that of the routine group,and the difference was statistically significant(P<0.05).Conclu-sion Continuous positive airway pressure assisted treatment of OSAHS can improve lung function,reduce apnea hy-popnea index and longest apnea time of patients,inhibit serum IL-6 level,and reduce the incidence of complications in patients.

Continuous positive airway pressure ventilationObstructive sleep apnea hypopnea syndromeLung functionLongest apnea timeInterleukin-6

熊和良、贾宗霞、洪凡凡、高静、张晓雪、马艳莉

展开 >

新疆生产建设兵团第六师医院呼吸与危重症医学科二科,新疆维吾尔自治区 五家渠 831300

新疆生产建设兵团第六师医院功能科,新疆维吾尔自治区 五家渠 831300

持续气道正压通气 阻塞性睡眠呼吸暂停低通气综合征 肺功能 最长呼吸暂停时间 白细胞介素-6

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(31)